Influence of escherichia coli endotoxin-induced endotoxaemia on the pharmacokinetics of enrofloxacin after intravenous administration in rabbits

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 53, Issue 8, 2006, Pages 410-414

  Elmas, M ^a   Yazar, E ^a   Uney, K ^a   Er, A ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ENROFLOXACIN; LIPOPOLYSACCHARIDE; QUINOLONE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; CROSSOVER PROCEDURE; ENDOTOXEMIA; ENTEROBACTER INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; RABBIT; RANDOMIZATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; ENDOTOXEMIA; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MALE; RABBITS; RANDOM ALLOCATION;

ANIMALIA; ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

EID: 33748806057     PISSN: 0931184X     EISSN: 14390442     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2006.00854.x     Document Type: Article

References (49)

1. Abdullah, A. S., and J. D. Baggot, 1984: Influence of Escherichia culi endotoxin-induced fever on pharmacokinetics of imidocarb in dogs and goats. Am. J. Vet. Res. 45, 2645-2648.
2. Abdullah, A. S., and J. D. Baggot, 1986: Influence of induced disease states on the disposition kinetics of imidocarb in goats. J. Vet. Pharmacol. Ther. 9, 192-197.
3. Anadon, A., M. R. Martinez-Larranaga, M. J. Diaz, P. Bringas, M. A. Martinez, and M. L. Fernandez-Cruz, 1995: Pharmacokinetics and residues of enrofloxacin in chickens. Am. J. Vet. Res. 56, 501-505.
4. Baggot, J. D., 2001: The Physiological Basis of Veterinary Clinical Pharmacology, 1st edn. Blackwell Science Ltd, London.
5. Blatteis, C. M., J. R. S. Hales, and A. A. Fawcett, 1988: Fever and regional blood flows in wethers and parturient ewes. J. Appl. Physiol. 65, 165-172.
6. Bregante, M. A., P. Saez, J. J. Aramayona, L. Fraile, M. A. Garcia, and C. Solans, 1999: Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. Am. J. Vet. Res. 60, 1111-1116.
7. Broome, R. C., D. L. Brooks, J. G. Babish, D. D. Copeland, and G. M. Conzelman, 1991: Pharmacokinetics properties of enrofloxacin in rabbits. Am. J. Vet. Res. 52, 1835-1841.
8. Cabanes, A., M. Arboix, J. M. Garcia-Anton, and F. Reig, 1992: Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. Am. J. Vet. Res. 53, 2090-2093.
9. Cabanes, A., F. Reig, J. M. Garcia-Anton, and M. Arboix, 1995: Sustained release of liposome encapsulated enrofloxacin after intramuscular administration in rabbits. Am. J. Vet. Res. 56, 1498-1501.
10. De Lucas, J. J., C. Rodriguez, S. Waxman, F. Gonzalez, M. L. De Vicente, and M. I. San Anders, 2004: Pharmacokinetics of enrofloxacin after single intravenous and intramuscular administration in young domestic ostrich (Struthio camelus). J. Vet. Pharmacol. Ther. 27, 119-122.
11. Elmas, M., and B Tras, 1999: Comparison of pharmacokinetic profiles of some antimicrobial agents in plasma and lymph fluids. Turkish J. Vet. Anim. Sci. 23, 591-599.
12. Elmas, M., E. Yazar, B. Tras, A. L. Bas, and A. Eryavuz, 2000: Pharmacokinetics and oral bioavailability of enrofloxacin in faunated and defaunated Angora goats. Rev. Med. Vet. 151, 507-510.
13. Elmas, M., B. Tras, S. Kaya, A. L. Bas, E. Yazar, and E. Yarsan, 2001 : Pharmacokinetics of enrofloxacin after single intravenous and intramuscular administration in Angora goats. Can. J. Vet. Res. 65, 64-67.
14. Elmas, M., E. Yazar, A. L. Bas, B. Tras, M. Bayezit, and K. Yapar, 2002: Comparative pharmacokinetics of enrofloxacin and tissue concentrations of parent drug and ciprofloxacin after intramuscular administrations of free and liposomc-encapsulated enrofloxacin in rabbits. J. Vet. Med. B 49, 507-512.
15. Elmas, M., E. Yazar, K. Uney, and A. Karabacak, 2006: Pharmacokinetics of flunixin after intravenous administration in healthy and endotoxaemic rabbits. Vet. Res. Commun. 30, 73-81.
16. Elsheikh, H. A., A. A. W. Taha, A. I. Khafallah, and I. A. M. Osman, 2002: Disposition kinetics of enrofloxacin (Baytril 5%) in sheep and goats following intravenous and intramuscular injection using a microbiological assay. Res. Vet. Sci. 73, 125-129.
17. Fraile, L. J., C. Martinez, J. J. Aramayona, A. R. Abadia, M. A. Bregante, and M. A. Garcia, 1997: Limited capacity of neonatal rabbits to eliminate enrofloxacin and ciprofloxacin. Vet. Q. 19, 162-167.
18. Haghoo, S., T. Hasegawa, M. Nadai, L. Wang, T. Nabeshima, and N. Kato, 1995: Effect of a bacterial lipopolysaccharide on biliary excretion of a β-lactam antibiotic, cefoperazone, in rats. Antimicrob. Agents Chemother. 39, 2258-2261.
19. Haritova, A., L. Lashev, and D. Pashov, 2003: Pharmacokinetics of enrofloxacin in lactating sheep. Res. Vet. Sci. 74, 241-245.
20. Hasegawa, T., and K. Takagi, 1999: Effects of bacterial endotoxin on drugs pharmacokinetics. Nagoya J. Med. Sci. 62, 11-28.
21. Hewet, J. A., and R. A. Roth, 1993: Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev. 45, 381-411.
22. Jernigan, A. D., R. C. Hatch, R. C. Wilson, J. Brown, and W. A. Crowell, 1988: Pathologic changes and tissue gentamicin concentrations after intravenous gentamicin administration in clinically normal and endotoxemic cats. Am. J. Vet. Res. 49, 613-617.
23. Jha, K., B. K. Roy, and R. C. P. Singh, 1996: The effect of induced fever on the biokinetics of norfloxacin and its interaction with probenecid in goats. Vet. Res. Commun. 20, 473-479.
24. Kaartinen, L., S. Pyorala, M. Moilanen, and S. Raisanen, 1997a: Pharmacokinetics of enrofloxacin in newborn and one-week-old calves. J. Vet. Pharmacol. Ther. 20, 479-482.
25. Kaartinen, L., S. Panu, and S. Pyorala, 1997b: Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Vet. J. 29, 378-381.
26. Khan, A. A., T. R. Slifer, F. G. Araujo, Y. Suzuki, and J. S. Remington, 2000: Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob. Agents Chemother. 44, 3169-3173.
27. Kumar, R., and J. K. Malik, 2003: Influence of endotoxin on the disposition kinetics and dosage regimens of oxytetracycline in calves. J. Vet. Pharmacol. Ther. 26, 159-164.
28. Marner, J. F., F. Beaudry, M. P. Ducharme, D. Fortin, J. P. Moreatu, R. Masse, and P. Vachon, 2001: A pharmacokinetics study of amoxycillin in febrile beagle dogs following repeated administrations of endotoxin. J. Vet. Pharmacol. Ther. 24, 379-383.
29. Mayeux, P. R., 1997: Pathobiology of lipopolysaccharide. J. Toxicol. Environ. Health 51, 415-435.
30. Monshouwer, M., and R. F. Witkamp, 2000: Cytochromes and cytokines: changes in drug disposition in animals during an acute phase response: a mini review. Vet. Q. 22, 17-20.
31. Post, L. O., C. V. Cope, D. E. Farrell, J. D. Baker, and M. J. Myers, 2002: Influence of porcine Actinobacillus pleurapneumoniae infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin. J. Pharmacol. Exp. Ther. 301, 217-222.
32. Post, L. O., C. V. Farrell, J. D. Baker, and M. J. Myers, 2003: The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine. J. Pharmacol. Exp. Ther. 304, 889-895.
33. Rantala, M., L. Kaartinen, E. Valimaki, M. Stryrman, M. Hiekkaranta, A. Niemi, L. Saari, and S. Pyorala, 2002: Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J. Vet. Pharmacol. Ther. 25, 251-258.
34. Rao, G. S., S. Ramesh, A. H. Ahmad, H. C. Tripathi, L. D. Sharma, and J. K. Malik, 2000: Effects of endotoxin-induced fever and probenecid on disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular administration of enrofloxacin in goats. J. Vet. Pharmacol. Ther. 23, 365-372.
35. Saitoh, T., E. Kokue, and M. Shimoda, 1999: The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits. J. Vet. Pharmacol. Ther. 22, 87-95.
36. Saitoh, T., E. Kokue, and M. Shimoda, 2000: The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits. J. Vet. Pharmacol. Ther. 23, 153-158.
37. Sarwari, A. R., and P. A. Mackowiak, 1996: The pharmacologic consequences of fever. Infect. Dis. Clin. North Am. 10, 21-32.
38. Scheer, M., 1987: Studies on antimicrobial activity of Baytril. Vet. Med. Rev. 2, 90-99.
39. Seguin, M. A., M. G. Papich, K. J. Sigle, N. M. Gibson, and J. K. Levy, 2004: Pharmacokinetics of enrofloxacin in neonatal kittens. Am. J. Vet. Res. 65, 350-356.
40. Shumaker, R. C., 1986: PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab. Rev. 17, 331-348.
41. Van Miert, A. S. J. P. A. M., 1990: Influence of febrile disease on the pharmacokinetics of veterinary drugs. Ann. Rech. Vet. 21, 11s-28s.
42. Van Miert, A. S. J. P. A. M., 2000: Trends in veterinary clinical and fundamental pharmacology: past and future in the Netherlands. Vet. Q. 22, 3-11.
43. Vancutsem, P. M., J. G. Babish, and W. S. Schwark, 1990: The flouroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet. 80, 173-186.
44. Wagner, J.G., 1975: Fundamentals of Clinical Pharmacokinetics. Drug Intelligence Pub Inc., Hamilton, IL, USA.
45. Walker, R. D., G. E. Stein, J. G. Hauptman, and K. H. McDonald, 1992: Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am. J. Vet. Res. 53, 2315-2319.
46. Waxman, S., M. D. San Andres, F. Gonzalez, J. J. De Lucas, M. I. San Andres, and C. Rodriguez, 2003: Influence of Eschericha call endotoxin-induced fever on the pharmacokinetic behavior of marbofloxacin after intravenous administration in goats. J. Vet. Pharmacol. Ther. 26, 65-69.
47. Yamaoka, K., T. Nakagawa, and T. Uno, 1978: Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6, 165-175.
48. Yazar, E., R. Col, S. Konyalioglu, Y. O. Birdane, M. Elmas, and A. L. Bas, 2004: Effect of vitamin E and prednisolone on biochemical and haematological parameters in endotoxaemic New Zealand white rabbits. Bull. Vet. Inst. Pulawy 48, 105-108.
49. Zeng, Z., and K. Fung, 1997: Effects of experimentally induced Escherichia coli infection on the pharmacokinetics of enrofloxacin in pigs. J. Vet. Pharmacol. Ther. 20 (Suppl. 1), 21-86.